Literature DB >> 21942940

Effects of parathyroid hormone-related protein and macrophage inflammatory protein-1α in Jurkat T-cells on tumor formation in vivo and expression of apoptosis regulatory genes in vitro.

Sherry T Shu1, Wessel P Dirksen, Lisa G Lanigan, Chelsea K Martin, Nanda K Thudi, Jillian L Werbeck, Soledad A Fernandez, Blake E Hildreth, Thomas J Rosol.   

Abstract

Parathyroid hormone-related protein (PTHrP) and macrophage inflammatory protein-1α (MIP-1α) have been implicated in the pathogenesis of adult T-cell leukemia/lymphoma, but their effects on T-cells have not been well studied. Here we analyzed the functions of PTHrP and MIP-1α on T-cell growth and death both in vitro and in vivo by overexpressing either factor in human Jurkat T-cells. PTHrP or MIP-1α did not affect Jurkat cell growth in vitro, but PTHrP increased their sensitivity to apoptosis. Importantly, PTHrP and MIP-1α decreased both tumor incidence and growth in vivo. To investigate possible mechanisms, polymerase chain reaction (PCR) arrays and real-time reverse transcription (RT)-PCR assays were performed. Both PTHrP and MIP-1α increased the expression of several factors including signal transducer and activator of transcription 4, tumor necrosis factor α, receptor activator of nuclear factor κB ligand and death-associated protein kinase 1, and decreased the expression of inhibitor of DNA binding 1, interferon γ and CD40 ligand in Jurkat cells. In addition, MIP-1α also increased the expression of transcription factor AP-2α and PTHrP increased expression of the vitamin D3 receptor. These data demonstrate that PTHrP and MIP-1α exert a profound antitumor effect presumably by increasing the sensitivity to apoptotic signals through modulation of transcription and apoptosis factors in T-cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21942940      PMCID: PMC3314295          DOI: 10.3109/10428194.2011.626883

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  83 in total

1.  1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes.

Authors:  H Reichel; H P Koeffler; A Tobler; A W Norman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

2.  The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells.

Authors:  M Roy; T Waldschmidt; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

3.  Increased serum levels of C-terminal parathyroid hormone-related protein in different diseases associated with HTLV-1 infection.

Authors:  K Yamaguchi; T Kiyokawa; T Watanabe; T Ideta; K Asayama; M Mochizuki; A Blank; K Takatsuki
Journal:  Leukemia       Date:  1994-10       Impact factor: 11.528

Review 4.  Hypercalcemia, parathyroid hormone-related protein expression and human T-cell leukemia virus infection.

Authors:  D Prager; J D Rosenblatt; E Ejima
Journal:  Leuk Lymphoma       Date:  1994-08

5.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death.

Authors:  L P Deiss; E Feinstein; H Berissi; O Cohen; A Kimchi
Journal:  Genes Dev       Date:  1995-01-01       Impact factor: 11.361

6.  Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways.

Authors:  A V Krishnan; S D Cramer; F R Bringhurst; D Feldman
Journal:  Endocrinology       Date:  1995-02       Impact factor: 4.736

Review 7.  The CD40 antigen and its ligand.

Authors:  J Banchereau; F Bazan; D Blanchard; F Brière; J P Galizzi; C van Kooten; Y J Liu; F Rousset; S Saeland
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  Human CD40-ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production.

Authors:  J F Gauchat; J P Aubry; G Mazzei; P Life; T Jomotte; G Elson; J Y Bonnefoy
Journal:  FEBS Lett       Date:  1993-01-11       Impact factor: 4.124

9.  Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene.

Authors:  T Watanabe; K Yamaguchi; K Takatsuki; M Osame; M Yoshida
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Interferon gamma plays a critical role in induced cell death of effector T cell: a possible third mechanism of self-tolerance.

Authors:  Y Liu; C A Janeway
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

View more
  4 in total

1.  Parathyroid hormone-related protein promotes bone loss in T-cell leukemia as well as in solid tumors.

Authors:  Nicole A Kohart; Said M Elshafae; Aylin A Demirer; Wessel P Dirksen; Justin T Breitbach; Sherry T Shu; Jingyu Xiang; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Leuk Lymphoma       Date:  2019-10-08

Review 2.  Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine.

Authors:  Laurie K McCauley; T John Martin
Journal:  J Bone Miner Res       Date:  2012-05-01       Impact factor: 6.741

3.  In Vivo Tumorigenesis, Osteolytic Sarcomas, and Tumorigenic Cell Lines from Transgenic Mice Expressing the Human T-Lymphotropic Virus Type 1 (HTLV-1) Tax Viral Oncogene.

Authors:  Lisa G Lanigan; Blake E Hildreth; Wessel P Dirksen; Jessica K Simmons; Chelsea K Martin; Jillian L Werbeck; Nandu K Thudi; Tracey L Papenfuss; Prosper N Boyaka; Ramiro E Toribio; Jerrold M Ward; Katherine N Weilbaecher; Thomas J Rosol
Journal:  Am J Pathol       Date:  2020-11-09       Impact factor: 4.307

4.  Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One.

Authors:  Eduardo Rocha Fukutani; Pablo Ivan Pereira Ramos; José Irahe Kasprzykowski; Lucas Gentil Azevedo; Moreno Magalhães de Souza Rodrigues; João Victor de Oliveira Pimenta Lima; Helton Fábio Santos de Araújo Junior; Kiyoshi Ferreira Fukutani; Artur Trancoso Lopo de Queiroz
Journal:  Front Genet       Date:  2019-11-08       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.